Premium Only Content

HyBryte™ by Soligenix: Transforming Cutaneous T-Cell Lymphoma Treatment
Soligenix (NASDAQ: SNGX) is a late-stage biopharmaceutical company specializing in developing and commercializing products to treat rare diseases with unmet medical needs. The Company's primary focus is on its Specialized BioTherapeutics business segment, which is responsible for the development of HyBryte™, a novel photodynamic therapy that uses safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL). The Company has successfully completed a Phase 3 study for HyBryte™ and is now negotiating a confirmatory Phase 3 pivotal study design with the US Food & Drug Administration, while also evaluating/pursuing potential HyBryte™ marketing approval ex-U.S. with the successfully completed Phase 3 study. Visit SNGXinfo.com to learn more.
-
15:16
Fit'n Fire
19 hours agoThe Beretta 92X Performance
862 -
5:33
Blackstone Griddles
13 hours agoBetty's Garlic Butter Clams on the Blackstone Griddle
379 -
11:06
Nicholas Bowling
1 day agoCollege Atheist Couldn't Accept This Simple Fact | GSU Recap
1692 -
31:20
Degenerate Plays
20 hours agoThe Batman Conundrum - Batman: Arkham Asylum : Part 9
631 -
19:04
CarlCrusher
16 hours agoThunder Strike Ranch UFO Night Watch
3031 -
4:21
Geoff_Tac
1 day agoSmith & Wesson Owners Need to See This!
623 -
8:11:50
MyronGainesX
1 day ago $60.85 earnedObama Treason, Syrian War, WNBA L, Mehdi vs Rightwingers, Candace v Nick!
152K58 -
3:14:26
PandaSub2000
1 day agoGame Boy Night 6 | ULTRA BEST AT GAMES (Original Live Version)
27.4K2 -
3:12:54
MattMorseTV
11 hours ago $23.49 earned🔴Reacting to the DEBATE.🔴20 BASED vs. 1 WOKE.🔴
95.4K47 -
43:10
The Mel K Show
18 hours agoMel K & Dr. Karlyn Borysenko | It's the Unions!?! Collectively Organizing the Fall of This Nation | 7-20-25
86.3K74